Epstein-Barr virus: an important vaccine target for cancer prevention.
Where this comes from
- Record sourced from PubMed, PMID 22049067.
- Also identified by DOI 10.1126/scitranslmed.3002878 and PMC identifier 3501269.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.
Medical subject headings
- Herpesvirus 4, Human
- Neoplasms
- Viral Vaccines